TEMFERON
LIVE

Serial Number

79262887

Owner

Genenta Science S.r.l.

Attorney

Bradley D. Crose

Filing Date

Jan 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TEMFERON Trademark

Serial Number: 79262887 • Registration: 6015854

TEMFERON is a trademark filed by Genenta Science S.r.l. on January 17, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Genenta Science S.r.l.

Via Olgettina 58

Entity Type: 99

Trademark Details

Filing Date

January 17, 2019

Registration Date

March 24, 2020

Published for Opposition

January 7, 2020

Goods & Services

Medicinal alcohol; medicinal drinks; medicinal infusions for treating cancer; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of cancer; nutritionally fortified beverages for medical purposes; medicinal preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for oncology cancer treatment; pharmaceutical preparations and substances, namely, anti-inflammatories; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for use in the field of anesthesia, namely, anesthetics; medicated body lotions for skin; medicinal preparations for treating cancer; biochemical preparations for treating cancer for medical purposes; biotechnological preparations for treating cancer for medical purposes; medicated bath preparations for therapeutic use; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for use in chemotherapy; agents for the reduction of tumors; medications used for the treatment of cancer; pharmaceutical preparations for the treatment of malignant tumor; medicines to treat cancer; medical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; preparations for medical purposes used for the detection of genetic mutations; preparations for medical purposes used for the detection of genetic predisposition

Medical research; design and development of medical technology; conducting clinical trials for others; services related to medical research, pharmacological and biological research; clinical research; human tissues analysis for medical research purposes; design and development of equipment in the field of medical research; providing information related to scientific and medical research in the sector of pharmaceutical and clinical experimentation; conducting of clinical experiments related to the field of therapies; research in the field of genetic therapies; consultancy in the field of genetic therapies for scientific research purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 24, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 25, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 30, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 30, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jan 4, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2019 CRFA
ASSIGNED TO LIE
Nov 25, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2019 TROA
REFUSAL PROCESSED BY IB
Sep 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 22, 2019 RFCS
REFUSAL PROCESSED BY MPU
Aug 22, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 27, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 26, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 20, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 11, 2019 REPR